Log In
BCIQ
Print this Print this
 

CP101

  Manage Alerts
Collapse Summary General Information
Company CharlestonPharma LLC
DescriptionHuman IgG1 mAb against nucleolin
Molecular Target Nucleolin
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today